Works matching Axillary lymph node dissection


Results: 2531
    1
    2
    3

    Combined analysis of the MF18‐02/MF18‐03 NEOSENTITURK studies: ypN‐positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is provided

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 1, p. 1, doi. 10.1002/cncr.35610
    By:
    • Muslumanoglu, Mahmut;
    • Cabioglu, Neslihan;
    • Igci, Abdullah;
    • Karanlık, Hasan;
    • Kocer, Havva Belma;
    • Senol, Kazim;
    • Mantoglu, Baris;
    • Tukenmez, Mustafa;
    • Çakmak, Guldeniz Karadeniz;
    • Ozkurt, Enver;
    • Gulcelik, Mehmet Ali;
    • Emiroglu, Selman;
    • Mollavelioglu, Baran;
    • Yildirim, Nilufer;
    • Bademler, Suleyman;
    • Zengel, Baha;
    • Trabulus, Didem Can;
    • Ugurlu, Mustafa Umit;
    • Uras, Cihan;
    • Ilgun, Serkan
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Axillary Lymph Node Dissection Rates and Prognosis From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer

    Published in:
    Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.741120
    By:
    • Gwark, Sungchan;
    • Noh, Woo Chul;
    • Ahn, Sei Hyun;
    • Lee, Eun Sook;
    • Jung, Yongsik;
    • Kim, Lee Su;
    • Han, Wonshik;
    • Nam, Seok Jin;
    • Gong, Gyungyub;
    • Kim, Seon-Ok;
    • Kim, Hee Jeong
    Publication type:
    Article
    20

    Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy.

    Published in:
    World Journal of Surgical Oncology, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12957-024-03547-7
    By:
    • Muslumanoglu, Mahmut;
    • Mollavelioglu, Baran;
    • Cabioglu, Neslihan;
    • Emiroglu, Selman;
    • Tukenmez, Mustafa;
    • Karanlık, Hasan;
    • Ozmen, Tolga;
    • Yılmaz, Ravza;
    • Comert, Rana Gunoz;
    • Onder, Semen;
    • Bayram, Aysel;
    • Simsek, Duygu Has;
    • Oflas, Melis;
    • Ibis, Kamuran;
    • Aydıner, Adnan;
    • Ozmen, Vahit;
    • Igci, Abdullah
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27

    Role of Absorbable Polysaccharide Hemostatic Powder in the Prevention of Complications After Axillary Lymph Node Dissection in Breast Cancer Patients: A Multicenter Retrospective Analysis.

    Published in:
    Medicina (1010660X), 2025, v. 61, n. 1, p. 79, doi. 10.3390/medicina61010079
    By:
    • Parisi, Simona;
    • Lucido, Francesco Saverio;
    • Fisone, Francesca;
    • Ruggiero, Roberto;
    • Tolone, Salvatore;
    • Iovino, Francesco;
    • Santoriello, Antonio;
    • Mongardini, Federico Maria;
    • Paolicelli, Maddalena;
    • Docimo, Ludovico;
    • Gambardella, Claudio
    Publication type:
    Article
    28

    The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro‐metastases.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 4, p. 4023, doi. 10.1002/cam4.5257
    By:
    • Houvenaeghel, Gilles;
    • de Nonneville, Alexandre;
    • Chopin, Nicolas;
    • Classe, Jean‐Marc;
    • Mazouni, Chafika;
    • Chauvet, Marie‐Pierre;
    • Reyal, Fabien;
    • Tunon de Lara, Christine;
    • Jouve, Eva;
    • Rouzier, Roman;
    • Daraï, Emile;
    • Gimbergues, Pierre;
    • Coutant, Charles;
    • Azuar, Anne Sophie;
    • Villet, Richard;
    • Crochet, Patrice;
    • Rua, Sandrine;
    • Bannier, Marie;
    • Cohen, Monique;
    • Boher, Jean‐Marie
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50